COVID-19Updates See latest Press Relases Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations 26 Dec 2025 9 Minutes 0 1238 ... Celularity Announces Closing of Financing Transactions 22 Dec 2025 10 Minutes 0 1240 ... Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision 18 Dec 2025 10 Minutes 0 1235 ... Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care 30 Oct 2025 8 Minutes 0 1245 ... Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease 14 Oct 2025 12 Minutes 0 1235 ... Load more
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations 26 Dec 2025 9 Minutes 0 1238 ...
Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision 18 Dec 2025 10 Minutes 0 1235 ...
Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care 30 Oct 2025 8 Minutes 0 1245 ...
Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease 14 Oct 2025 12 Minutes 0 1235 ...
